P2RX7 and neoplasm: ENTPD1, IL17A, and P2RX7 were downregulated, while HSP90AA1, PIK3CA, and NT5E were upregulated, indicating that ENTPD1, IL17A, and P2RX7 might negatively affect tumor development and result in better outcome.